Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market

摘要

BackgroundThe price of antiretroviral drugs (ARVs) in low income countries declined steadily in recent years. This raises concerns about the commercial viability of the market of ARVs in low income countries.